Back to JVIR CME 2017 November
JVIR CME 2017 November 1.00 SA-CME

JVIR CME 2017 November

  • Article: Long-term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver
  • Free for SIR members
  • 1 SA-CME credit
  • Expires Nov. 30, 2020
  • Credits:
    1.00 Self-Assessment CME
    1.00 CME
    1.00 Participation
    • List Price: $20.00
    • Member Price: Free
     
    Want to save more?
    Log into see if you qualify for a lower rate.
    Members save $20.00 or more Join
    Item Details:

    This single-center retrospective study determines the long-term hepatotoxicity of Yttrium-90 Radioembolization (Y90) in patients treated for metastatic neuroendocrine tumor (mNET), and evaluates if imaging and laboratory findings of cirrhosis-like morphology has limited clinical symptoms. This...

    Back to JVIR CME 2017 November
    View More View Less

    Text/HTML

    Contact us:
    Physical Products: 888-695-9733 or SIR@brightkey.net
    Electronic Products: 703-460-5590 or enicholson@sirweb.org

    0